These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31499528)

  • 1. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial.
    Manson JE; Aragaki AK; Bassuk SS; Chlebowski RT; Anderson GL; Rossouw JE; Howard BV; Thomson CA; Stefanick ML; Kaunitz AM; Crandall CJ; Eaton CB; Henderson VW; Liu S; Luo J; Rohan T; Shadyab AH; Wells G; Wactawski-Wende J; Prentice RL;
    Ann Intern Med; 2019 Sep; 171(6):406-414. PubMed ID: 31499528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.
    Manson JE; Chlebowski RT; Stefanick ML; Aragaki AK; Rossouw JE; Prentice RL; Anderson G; Howard BV; Thomson CA; LaCroix AZ; Wactawski-Wende J; Jackson RD; Limacher M; Margolis KL; Wassertheil-Smoller S; Beresford SA; Cauley JA; Eaton CB; Gass M; Hsia J; Johnson KC; Kooperberg C; Kuller LH; Lewis CE; Liu S; Martin LW; Ockene JK; O'Sullivan MJ; Powell LH; Simon MS; Van Horn L; Vitolins MZ; Wallace RB
    JAMA; 2013 Oct; 310(13):1353-68. PubMed ID: 24084921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial.
    LaCroix AZ; Chlebowski RT; Manson JE; Aragaki AK; Johnson KC; Martin L; Margolis KL; Stefanick ML; Brzyski R; Curb JD; Howard BV; Lewis CE; Wactawski-Wende J;
    JAMA; 2011 Apr; 305(13):1305-14. PubMed ID: 21467283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
    Chlebowski RT; Anderson GL; Aragaki AK; Manson JE; Stefanick ML; Pan K; Barrington W; Kuller LH; Simon MS; Lane D; Johnson KC; Rohan TE; Gass MLS; Cauley JA; Paskett ED; Sattari M; Prentice RL
    JAMA; 2020 Jul; 324(4):369-380. PubMed ID: 32721007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials.
    Manson JE; Aragaki AK; Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Chlebowski RT; Howard BV; Thomson CA; Margolis KL; Lewis CE; Stefanick ML; Jackson RD; Johnson KC; Martin LW; Shumaker SA; Espeland MA; Wactawski-Wende J;
    JAMA; 2017 Sep; 318(10):927-938. PubMed ID: 28898378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
    Heiss G; Wallace R; Anderson GL; Aragaki A; Beresford SA; Brzyski R; Chlebowski RT; Gass M; LaCroix A; Manson JE; Prentice RL; Rossouw J; Stefanick ML;
    JAMA; 2008 Mar; 299(9):1036-45. PubMed ID: 18319414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
    Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
    Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
    Stefanick ML; Anderson GL; Margolis KL; Hendrix SL; Rodabough RJ; Paskett ED; Lane DS; Hubbell FA; Assaf AR; Sarto GE; Schenken RS; Yasmeen S; Lessin L; Chlebowski RT;
    JAMA; 2006 Apr; 295(14):1647-57. PubMed ID: 16609086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial.
    Jackson RD; Wactawski-Wende J; LaCroix AZ; Pettinger M; Yood RA; Watts NB; Robbins JA; Lewis CE; Beresford SA; Ko MG; Naughton MJ; Satterfield S; Bassford T;
    J Bone Miner Res; 2006 Jun; 21(6):817-28. PubMed ID: 16753012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial.
    Chlebowski RT; Barrington W; Aragaki AK; Manson JE; Sarto G; OʼSullivan MJ; Wu D; Cauley JA; Qi L; Wallace RL; Prentice RL
    Menopause; 2017 Feb; 24(2):133-141. PubMed ID: 27749739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study.
    Shufelt C; Bairey Merz CN; Pettinger MB; Choi L; Chlebowski R; Crandall CJ; Liu S; Lane D; Prentice R; Manson JE;
    Menopause; 2018 Sep; 25(9):985-991. PubMed ID: 29738414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause.
    Prentice RL; Manson JE; Langer RD; Anderson GL; Pettinger M; Jackson RD; Johnson KC; Kuller LH; Lane DS; Wactawski-Wende J; Brzyski R; Allison M; Ockene J; Sarto G; Rossouw JE
    Am J Epidemiol; 2009 Jul; 170(1):12-23. PubMed ID: 19468079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials.
    Swica Y; Warren MP; Manson JE; Aragaki AK; Bassuk SS; Shimbo D; Kaunitz A; Rossouw J; Stefanick ML; Womack CR
    Menopause; 2018 Jul; 25(7):753-761. PubMed ID: 29381666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Trial Evaluation of the Benefits and Risks of Menopausal Hormone Therapy Among Women 50-59 Years of Age.
    Prentice RL; Aragaki AK; Chlebowski RT; Rossouw JE; Anderson GL; Stefanick ML; Wactawski-Wende J; Kuller LH; Wallace R; Johnson KC; Shadyab AH; Gass M; Manson JE
    Am J Epidemiol; 2021 Feb; 190(3):365-375. PubMed ID: 33025002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal Hormone Therapy and Ovarian and Endometrial Cancers: Long-Term Follow-Up of the Women's Health Initiative Randomized Trials.
    Chlebowski RT; Aragaki AK; Pan K; Haque R; Rohan TE; Song M; Wactawski-Wende J; Lane DS; Harris HR; Strickler H; Kauntiz AM; Runowicz CD
    J Clin Oncol; 2024 Oct; 42(30):3537-3549. PubMed ID: 39173088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.